Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 27, 2010


Didier Hirsch has been named chief financial officer and senior vice president at Agilent Technologies. Hirsch has been acting CFO and VP of corporate controllership and tax at the company since April. Before joining Agilent, he was director of finance and administration for Hewlett-Packard Europe, Middle East, and Africa, and before that he held a similar post in HP's Asia Pacific business.

Anath Shalev has been named the director of the University of Alabama at Birmingham Comprehensive Diabetes Center, effective Oct. 1. Shalev also will be a professor of medicine in the division of endocrinology, diabetes, and metabolism at UAB. She currently is director of endocrinology, diabetes and metabolism research in the department of medicine at the University of Wisconsin-Madison.

Shalev's laboratory uses array technology to examine potential targets for therapeutic interventions to block apoptosis of pancreatic beta cells. Shalev earned her medical degree from the University of Basel in Switzerland in 1993 and completed a post-graduate scholarship in experimental medicine and biology at the University of Zurich and a research fellowship at Harvard University.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.